Bruno Cassinat

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Jean‐Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret et al. · Blood · 2008 · 570 citations · Full text

Medicine, Hematology, Pharmacology +7

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Jean‐Jacques Kiladjian, Francisco Cervantes, Frank W.G. Leebeek et al. · Blood · 2008 · 358 citations · Full text

Medicine, Genetics, Hematology +14

Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients1 2

Éric Thervet, Dany Anglicheau, Barry P. King et al. · Transplantation · 2003 · 300 citations

Medicine, Pharmacokinetics, Pharmacology +17

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Jean Donadieu, Thierry Leblanc, Brigitte Bader‐Meunier et al. · PubMed · 2005 · 288 citations

Medicine, Hematology, Oncology +15

DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia

Anita R. Mistry, Carolyn A. Felix, Ryan J. Whitmarsh et al. · New England Journal of Medicine · 2005 · 281 citations

Medicine, Molecular Biology, Oncology +16